Table 1. Baseline characteristics: mean (SD) for continuous variables and number (%) for categorical variables by trial arm.
| Intervention (n = 379) | Control (n = 370) | |
| Continuous variables | Mean value (SD) | |
| Age (years) | 55·4 (8·0) | 55·7 (8·2) |
| BMI (kgm−2) | 31·4 (5·0) | 31·0 (4·8) |
| Waist (cm) | 102·5 (11·2) | 101·1 (10·4) |
| Hip (cm) | 109·8 (10·3) | 108·7 (10·8) |
| Weight (kg) | 88·2 (14·8) | 85·7 (13·6) |
| FINDRISC score11 | 14·2 (4·0) | 14·0 (4·2) |
| Plasma glucose (mmol/l) | ||
| Fasting | 6·0 (0·8) | 6·0 (0·7) |
| 60 minute | 11·2 (2·0)a | 11·1 (2·1)b |
| 120 minute | 8·8 (1·5) | 8·7 (1·4) |
| Plasma insulin (mU/l) | ||
| Fasting | 13·3 (7·8)c | 12·8 (6·6)d |
| 120 minute | 84·7 (61·0)e | 83·4 (56·7)f |
| Blood pressure (systolic) (mmHg) | 139 (17) | 137 (16) |
| Blood pressure (diastolic)(mmHg) | 84 (9) | 85 (9) |
| HbA1c (%) | 5·7 (0·5)g | 5·7 (0·5)h |
| Cholesterol (mmoll−1 ) | 5·5 (1·1)i | 5·5 (1·0)j |
| Triglycerides (mmoll−1 ) | 1·7 (0·9)i | 1·7 (0·8)j |
| HDL Cholesterol (mmoll−1 ) | 1·2 (0·3)i | 1·2 (0·3)i |
a
n = 348.
b
n = 330.
c
n = 354.
d
n = 348.
e
n = 351.
f
n = 344.
g
n = 370.
h
n = 362.
I
n = 375.
j
n = 364.